Earlier today my colleagues
Ed Boyden,
Rutledge Ellis-Behnke, and I hosted the finale session of our 2009 joint MIT Media Lab -
Brain & Cognitive Science - Biological Engineering - Health Science & Technology - Sloan School of Management
Neurotechnology Ventures seminar. Neurotech is an emerging and important theme which embraces a broad array of issues and opportunities including:
Neuroimaging, Neurology/Psychiatry Diagnosis, Rehabilitation, Neurosurgery, Neuropharmacology, Brain Stimulation, Prosthetics, Sensory and Motor Augmentation, Gaming, Learning, Neuroveterinary Solutions, Regenerative Neuromedicine, and more. I'm pretty happy with these new venture proposals, including...
- NeuMitra ~ Anxiety Sensing and Advisory System
- Luxalzion ~ Small Molecule Alzheimer's Therapy
- SeventhSense ~ Quadraplegic Brainwave Interface
- WizGum ~ Controlled-Delivery Energy Gum
- Signature Studios ~ fMRI Neurocinematics
- VitroStroke ~ Vitrification for Neurosurgery
- SafetySpine ~ Back-Strain Sensory Alert Brace
- Foveo Health ~ Diabetes Management Informatics
And, yes indeed, I'm here afterwards at the
Muddy Charles Pub, MIT's fountainhead of over-the-counter neuroceuticals;-) This was another pretty good year of neuroventures. As I noted last year, the emergent
Neurotechnology Ventures Cluster in New England is blossoming as a substantial element of our greater Boston biotechnology - life-science - healthcare megacluster.
No comments:
Post a Comment